OSI Systems Reports Fiscal 2021 Second Quarter Financial Results

Rhea-AI Summary

OSI Systems, Inc. (NASDAQ: OSIS) reported its financial results for Q2 and the first half of fiscal 2021, highlighting record adjusted earnings despite revenue declines. Q2 revenues were $276.0 million, down from $305.3 million year-over-year, with net income of $20.0 million, or $1.10 per diluted share. Non-GAAP net income saw an increase to $24.6 million, or $1.35 per share. The company has raised its revenue guidance to $1.110 - $1.145 billion and non-GAAP EPS guidance to $5.00 - $5.35, reflecting a strong backlog of $1.031 billion.

Positive

• Raised fiscal 2021 revenue guidance to $1.110 - $1.145 billion from $1.100 - $1.142 billion.
• Increased non-GAAP diluted EPS guidance to $5.00 - $5.35 from $4.65 - $5.10.
• Strong operational performance in the Optoelectronics and Manufacturing division with record second quarter sales.

Negative

• Q2 revenues decreased 9.6% year-over-year from $305.3 million to $276.0 million.
• Net income for Q2 fell to $20.0 million, down from $21.0 million year-over-year.

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced financial results for the three and six months ended December 31, 2020.

Deepak Chopra, OSI Systems’ Chairman and Chief Executive Officer, stated, “We are pleased with our second quarter performance as we delivered record adjusted earnings despite the continued impact of the COVID-19 pandemic. With a healthy backlog and robust pipeline of opportunities, we believe we are well positioned as we enter the second half of fiscal 2021.”

For the second quarter of fiscal 2021, the Company reported revenues of $276.0 million compared to $305.3 million reported for the second quarter of fiscal 2020. Net income for the second quarter of fiscal 2021 was $20.0 million, or $1.10 per diluted share, compared to net income of $21.0 million, or $1.12 per diluted share, for the second quarter of fiscal 2020. Non-GAAP net income for the second quarter of fiscal 2021 was $24.6 million, or $1.35 per diluted share, compared to non-GAAP net income for the fiscal 2020 second quarter of $23.8 million, or $1.27 per diluted share.

For the six months ended December 31, 2020, revenues were $530.9 million compared to $596.2 million in the same period a year ago. Net income for the six months ended December 31, 2020 was $29.4 million, or $1.61 per diluted share, compared with $41.7 million, or $2.22 per diluted share, for the same period a year ago. Non-GAAP net income for the six months ended December 31, 2020 was $44.1 million, or $2.41 per diluted share, compared with non-GAAP net income of $41.0 million, or $2.18 per diluted share, for the comparable prior-year period.

During the quarter ended December 31, 2020, the Company’s book-to-bill ratio was 1.1. As of December 31, 2020, the Company's backlog was $1,031 million compared to $861 million as of June 30, 2020. Operating cash flow during the quarter ended December 31, 2020 was $35.6 million, and capital expenditures were $4.7 million.

Mr. Chopra commented, “As expected, the Security division reported a reduction in year-over-year revenues as we continue to be impacted by the pandemic. However, with strong operational performance, we maintained our adjusted operating margin. We have captured multiple recent awards as we continue to exhibit our leadership in the global marketplace.”

Mr. Chopra continued, “Our Optoelectronics and Manufacturing division again delivered outstanding results with record second quarter sales and operating income. We continue to see strong global demand, and, with record Opto backlog, we expect the division to deliver strong results for the remainder of fiscal 2021.”

Mr. Chopra concluded, “We continued building on our positive momentum in the Healthcare division resulting in a 31% increase in second quarter year-over-year revenue and noteworthy operating income growth. This marks the fourth consecutive quarter of significant adjusted operating margin expansion in the division. Our Healthcare backlog is solid, and we will continue to focus on enhancing our core products and developing new products.”

Fiscal Year 2021 Outlook

	Current Updated Guidance		Previous Guidance
Revenues	$1.110 billion - $1.145 billion		$1.100 billion - $1.142 billion
Non-GAAP Diluted Earnings Per Share	$5.00 - $5.35		$4.65 - $5.10

For fiscal year 2021, the Company is raising its revenue guidance to a range of $1.110 billion to $1.145 billion and is raising its non-GAAP diluted earnings per share guidance to $5.00 to $5.35. Actual revenues and non-GAAP diluted earnings per share for fiscal 2021 could vary from this guidance due to factors discussed under “Forward-Looking Statements” or other factors.

The Company’s fiscal 2021 diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for non-GAAP diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items included in the calculation of GAAP diluted EPS but excluded in the calculation of non-GAAP diluted EPS, such as acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control, or cannot otherwise be reasonably predicted. For the same reasons, the Company is unable to address the significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the corresponding GAAP financial measure, being materially different from projected non-GAAP diluted EPS.

Presentation of Non-GAAP Financial Measures

This earnings release includes a presentation of non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP operating income (loss) by segment and non-GAAP operating margin, all of which are non-GAAP financial measures. The presentation of these non-GAAP figures for the three and six months ended December 31, 2019 and 2020 is provided to allow for the comparison of the underlying performance of the Company, net of impairment, restructuring and other charges (including certain legal costs), amortization of intangible assets acquired through business acquisitions and non-cash interest expense primarily related to convertible debt, and their associated tax effects, and the impact of discrete income tax items. Although we exclude amortization of acquired intangible assets from our non-GAAP figures, we believe that it is important for investors to understand that revenue generated from such intangibles is included within revenue in determining non-GAAP financial measures of the Company. Management believes that these non-GAAP financial measures provide (i) enhanced insight into the ongoing operations of the Company, (ii) meaningful information regarding the Company’s financial results (excluding amounts management does not view as reflective of ongoing operating results) for purposes of planning, forecasting, and assessing the performance of the Company’s businesses, (iii) a meaningful comparison of financial results of the current period against results of past periods, and (iv) financial results that are generally more comparable to financial results of peer companies than are GAAP figures. Non-GAAP financial measures should not be assessed in isolation or as a substitute for measures of financial performance prepared in accordance with GAAP. These non-GAAP measures may not be the same as measures used by other companies due to possible differences in methods and in the items or events for which adjustments are made.

Reconciliations of GAAP to non-GAAP financial information are provided in the accompanying tables. The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.

Conference Call Information

The Company will host a conference call and simultaneous webcast beginning at 9:00am PT (12:00pm ET) today to discuss its results for the second quarter of fiscal 2021. To listen, please visit the Investor Relations section of the OSI Systems website, http://investors.osi-systems.com/index.cfm and follow the link that will be posted on the front page. A replay of the webcast will be available beginning shortly after the conclusion of the conference call until February 11, 2021. The replay can either be accessed through the Company’s website, www.osi-systems.com, or by telephonic replay by calling 1-855-859-2056 and entering the conference call identification number 8287891 when prompted for the replay code.

About OSI Systems

OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end-product markets. For more information on OSI Systems or its subsidiary companies, visit www.osi-systems.com. News Filter: OSIS-E

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Forward-looking statements include, but are not limited to, information provided regarding expected revenues, earnings, growth, operational performance and impact of the COVID-19 pandemic in fiscal 2021. The Company could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; unanticipated impacts of sequestration and other U.S. Government budget control provisions; changes in domestic and foreign government spending and budgetary, procurement and trade policies adverse to the Company's businesses; global economic uncertainty; impact on the Company’s business related to or resulting from the COVID-19 pandemic such as material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on the Company’s ability to execute business plans; unfavorable currency exchange rate fluctuations; effect of changes in tax legislation; market acceptance of the Company's new and existing technologies, products, and services; the Company's ability to win new business and convert orders received to sales within the fiscal year; enforcement actions in respect of any noncompliance with laws and regulations, including export control and environmental regulations and the matters that are the subject of some or all of the Company's investigations and compliance reviews; contract and regulatory compliance matters, and actions which, if brought, could result in judgments, settlements, fines, injunctions, debarment, or penalties; and other risks and uncertainties, including, but not limited to, those detailed herein and from time to time in the Company's Securities and Exchange Commission filings, which could have a material and adverse impact on the Company's business, financial condition, and results of operations. Many of the referenced risks could be amplified by the magnitude and duration of the COVID-19 pandemic. For additional information on these and other factors that could cause the Company's future results to differ materially from those in any forward-looking statements, see the section titled "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. The Company assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so under federal securities laws.

OSI SYSTEMS, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
	Three Months Ended December 31,										Six Months Ended December 31,
	2019				2020						2019				2020
Revenue:
Products	$	223,772		$		208,367				$		433,533			$		391,114
Services	81,570			67,642						162,661					139,803
Total revenues	305,342				276,009						596,194					530,917
Cost of goods sold:
Products	148,709				139,893						295,051					264,734
Services	45,860				34,035						91,159					68,351
Total cost of goods sold	194,569				173,928						386,210					333,085
Gross profit	110,773				102,081						209,984					197,832
Operating expenses:
Selling, general and administrative	63,902				56,101						126,079					114,718
Research and development	14,881				13,784						29,127					25,866
Restructuring and other charges (benefit), net	(929)				(162)						(3,028)					8,197
Total operating expenses	77,854				69,723						152,178					148,781
Income from operations	32,919				32,358						57,806					49,051
Interest expense and other, net	(4,844)				(4,233)						(9,580)					(8,422)
Income before income taxes	28,075				28,125						48,226					40,629
Provision for income taxes	(7,089)				(8,087)						(6,497)					(11,247)
Net income	$	20,986			$		20,038				$	41,729			$		29,382
Diluted earnings per share	$	1.12			$		1.10				$ 2.22					$	1.61
Weighted average shares outstanding – diluted	18,682				18,196						18,783					18,266

UNAUDITED SEGMENT INFORMATION (in thousands)
	Three Months Ended December 31,								Six Months Ended December 31,
	2019				2020				2019				2020
Revenues – by Segment:
Security division	$	202,437			$	145,236			$	391,401			$	280,011
Healthcare division		41,992				54,895				82,200				106,398
Optoelectronics and Manufacturing division (including intersegment revenues)		72,806				87,521				146,444				167,435
Intersegment revenues eliminations		(11,893	)			(11,643	)			(23,851	)			(22,927	)
Total	$	305,342			$	276,009			$	596,194			$	530,917
Operating income (loss) – by Segment:
Security division	$	28,562			$	19,776			$	48,880			$	28,682
Healthcare division		1,294				9,323				4,111				18,307
Optoelectronics and Manufacturing division		9,018				10,414				17,787				19,154
Corporate		(6,080	)			(7,361	)			(13,417	)			(16,817	)
Intersegment eliminations		125				206				445				(275	)
Total	$	32,919			$	32,358			$	57,806			$	49,051

OSI SYSTEMS, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
	June 30, 2020			December 31, 2020
Assets
Cash and cash equivalents	$	76,102		$	72,575
Accounts receivable, net	269,840			263,071
Inventories	241,226			266,190
Other current assets	30,541			32,588
Total current assets	617,709			634,424
Property and equipment, net	127,936			127,875
Goodwill	310,627			318,287
Intangible assets, net	128,279			132,076
Other non-current assets	83,990			88,141
Total Assets	$	1,268,541		$	1,300,803
Liabilities and Stockholders' Equity
Bank lines of credit	$	59,000		$	18,000
Current portion of long-term debt	926			947
Accounts payable and accrued expenses	154,487			162,595
Other current liabilities	115,688			151,851
Total current liabilities	330,101			333,393
Long-term debt	267,072			271,667
Other long-term liabilities	99,216			108,107
Total liabilities	696,389			713,167
Total stockholders’ equity	572,152			587,636
Total Liabilities and Stockholders’ Equity	$	1,268,541		$	1,300,803

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME AND EARNINGS PER SHARE (in thousands, except earnings per share data)
	Three Months Ended December 31,																	Six Months Ended December 31,
	2019								2020									2019								2020
	Net income				EPS				Net income				EPS					Net income				EPS				Net income				EPS
GAAP basis	$	20,986			$	1.12			$	20,038			$	1.10				$	41,729			$	2.22			$	29,382			$	1.61
Restructuring and other charges (benefit), net		(929	)			(0.05	)			(162	)			(0.01	)				(3,028	)			(0.16	)			8,197				0.45
Amortization of acquired intangible assets		3,566				0.19				3,704				0.20					7,163				0.38				7,480				0.41
Non-cash interest		2,239				0.12				2,260				0.12					4,402				0.23				4,486				0.25
Tax benefit of above adjustments		(1,352	)			(0.07	)			(1,600	)			(0.08	)				(2,373	)			(0.13	)			(5,546	)			(0.31	)
Discrete tax items		(696	)			(0.04	)			347				0.02					(6,910	)			(0.36	)			71				--
Non-GAAP basis	$	23,814			$	1.27			$	24,587			$	1.35				$	40,983			$	2.18			$	44,070			$	2.41

RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT (in thousands, except percentages)
Three Months Ended December 31, 2019
		Security Division						Healthcare Division						Optoelectronics and Manufacturing Division										Corporate / Elimination				Total
					% of Sales						% of Sales										% of Sales											% of Sales
GAAP basis – operating income (loss)		$	28,562		14.1	%		$	1,294		3.1	%		$				9,018			12.4	%		$	(5,955	)		$	32,919			10.8	%
Restructuring and other charges (benefit), net			405		0.2	%			--		--							30			--				(1,364	)			(929	)		(0.4	%)
Amortization of acquired intangible assets			2,792		1.4	%			--		--							774			1.1	%			- -				3,566			1.2	%
Non-GAAP basis– operating income (loss)		$	31,759		15.7	%		$	1,294		3.1	%		$				9,822			13.5	%		$	(7,319	)		$	35,556			11.6	%
Three Months Ended December 31, 2020
		Security Division						Healthcare Division						Optoelectronics and Manufacturing Division										Corporate / Elimination				Total
					% of Sales						% of Sales									% of Sales												% of Sales
GAAP basis – operating income (loss)		$	19,776		13.6	%		$	9,323		17.0	%		$		10,414				11.9		%		$	(7,155	)		$	32,358			11.7	%
Restructuring and other charges (benefit), net			269		0.2	%			27		--					--				--					(458	)			(162	)		(0.1	%)
Amortization of acquired intangible assets			2,732		1.9	%			201		0.4	%				771				0.9		%			- -				3,704			1.4	%
Non-GAAP basis– operating income (loss)		$	22,777		15.7	%		$	9,551		17.4	%		$		11,185				12.8		%		$	(7,613	)		$	35,900			13.0	%

Six Months Ended December 31, 2019
		Security Division						Healthcare Division						Optoelectronics and Manufacturing Division						Corporate / Elimination				Total
					% of Sales						% of Sales						% of Sales											% of Sales
GAAP basis – operating income (loss)		$	48,880		12.5	%		$	4,111		5.0	%		$	17,787		12.1	%		$	(12,972	)		$	57,806			9.7	%
Restructuring and other charges (benefit), net			405		0.1	%			--		--				17		--				(3,450	)			(3,028	)		(0.5	%)
Amortization of acquired intangible assets			5,592		1.4	%			--		--				1,571		1.1	%			--				7,163			1.2	%
Non-GAAP basis– operating income (loss)		$	54,877		14.0	%		$	4,111		5.0	%		$	19,375		13.2	%		$	(16,422	)		$	61,941			10.4	%
Six Months Ended December 31, 2020
		Security Division						Healthcare Division						Optoelectronics and Manufacturing Division						Corporate / Elimination				Total
					% of Sales						% of Sales						% of Sales											% of Sales
GAAP basis – operating income (loss)		$	28,682		10.2	%		$	18,307		17.2	%		$	19,154		11.4	%		$	(17,092	)		$	49,051			9.2	%
Restructuring and other charges (benefit), net			8,522		3.1	%			27		--				146		0.1	%			(498	)			8,197			1.6	%
Amortization of acquired intangible assets			5,545		2.0	%			403		0.4	%			1,532		0.9	%			--				7,480			1.4	%
Non-GAAP basis– operating income (loss)		$	42,749		15.3	%		$	18,737		17.6	%		$	20,832		12.4	%		$	(17,590	)		$	64,728			12.2	%

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005394/en/

FAQ

What were OSI Systems' financial results for Q2 fiscal 2021?

OSI Systems reported Q2 revenues of $276.0 million, net income of $20.0 million, and non-GAAP net income of $24.6 million.

Did OSI Systems change its revenue guidance for fiscal 2021?

Yes, OSI Systems raised its revenue guidance to a range of $1.110 billion to $1.145 billion.

What were the non-GAAP EPS figures for OSI Systems for Q2 fiscal 2021?

The non-GAAP diluted EPS for Q2 fiscal 2021 was $1.35, up from $1.27 in the same quarter last year.

What is the status of OSI Systems' backlog as of December 31, 2020?

As of December 31, 2020, OSI Systems had a backlog of $1,031 million, up from $861 million as of June 30, 2020.

How did OSI Systems' Security division perform in Q2 fiscal 2021?

The Security division reported a reduction in year-over-year revenues due to the ongoing impact of the COVID-19 pandemic.